Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by Nevermind21on Nov 23, 2018 5:58pm
156 Views
Post# 29016230

RE:RE:RE:Does this make the success of PPP001 very low?

RE:RE:RE:Does this make the success of PPP001 very low?Hi Green, I think what the comissioner is actually saying isn't so bad but I can understand how reading that it may make you question your investment and the FDA's stance on allowing this. I mean, it's common sense to do such a thing - it would be blind to not seeing as you are invested in a bio pharma trial. The commissioner even says he is still open to the possiblity so that is great. So I am not going to show up and pretend I am the king of this board and try to shoo you away with belittling your topic. 

I mean, any average person could tell you that it really isn't the optimal delivery method, but with that being said cannabis is a whole different beast that is only being studied in depth under the spot light recently with clinical trials from all companies showing up left right and center. Guy has told us that studies are showing that terpenes which can be release with the act of burning the plant are catually different and might have an outcome that relieves more pain then say, ingesting oil or edibles. Since our initial trial is for cancer patients, it makes sense that they would have the method that relieves most pain. Which I think that point alone will make it awfully hard to ignore by the FDA/Health Canada, even if the drug gets to the body via the lungs. 

But the picture is way deeper then that. I think what Tetra Bio Pharma has releaized is that they must start with the core of the plant and work their way out from there. That is why this investment is lucrative and amazing imo. Just look at the evidence of their pipeline and look at the possibilties alone for a version of PPP001 in oils and when vaping which they have began. Who knows what the next branch is around the corner. The quesiton is: does FDA and health canada look at it from this exact perspective? I think they do because FDA has given PPP0001 some attention with Orphan Drug Status. Health Canada has worked and approved multiple additional trials branching out from PPP0001, so wouldn't you think that if they keep doing approving these (Fetenal trial, fiboriyamgia trial, oil capsulte trial - all using PPP001 as a base), then the evidence it works is all but there already? If all this goes as plan I am not kidding when the numbers are pointing to us being a huge profit maker and having first mover advantage in a massive way world wide.

The seriously only scary thing about this company is the fact that you are betting on most of the company value on getting this drug approved. Despite how brainwashed you are in your investment, it is a fact that the value is hinging on that. It's right around the corner though and I think if you do a little calculations and read the developing news releases the past few months, it's sounding like they will ;)
<< Previous
Bullboard Posts
Next >>